Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Bimatoprost since 2013?

What pharmacies pay, not what you pay. Bimatoprost has 3 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Bimatoprost 0.03% Eye Drops: $36.12 per unit at the 2015 survey and $6.57 at 2026 (−82%, thin).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Bimatoprost3 products in NADAC
2products with a price history
  1. Bimatoprost has 3 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. 2 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Bimatoprost 0.03% Eye Drops

Generic

$36.12 per mL at the 2015 year-end survey (1 NDC) and $6.57 at the 2026 survey (15 NDCs): −82%, a thin comparison.

$0$38.242015: median $36.12 per mL, 1 NDC priced2016: median $37.40 per mL, 1 NDC priced2017: median $34.07 per mL, 1 NDC priced2018: median $38.24 per mL, 1 NDC priced2019: median $36.10 per mL, 4 NDCs priced2020: median $29.11 per mL, 9 NDCs priced2021: median $29.78 per mL, 10 NDCs priced2022: median $27.88 per mL, 10 NDCs priced2023: median $20.15 per mL, 12 NDCs priced2024: median $12.64 per mL, 17 NDCs priced2025: median $10.10 per mL, 15 NDCs priced2026: median $6.57 per mL, 15 NDCs priced2015201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2015 (2015-12-30)$36.121
2016 (2016-12-28)$37.401
2017 (2017-12-27)$34.071
2018 (2018-12-26)$38.241
2019 (2019-12-25)$36.104
2020 (2020-12-30)$29.11$26.02 to $29.119
2021 (2021-12-29)$29.78$29.43 to $30.1210
2022 (2022-12-28)$27.88$24.64 to $31.1110
2023 (2023-12-27)$20.15$19.73 to $20.5812
2024 (2024-12-25)$12.64$10.55 to $27.1317
2025 (2025-12-31)$10.10$9.62 to $23.8015
2026 (2026-11-11)$6.57$3.82 to $7.7515

Bimatoprost 0.03% Eyelash Soln

Generic

$29.12 per mL at the 2017 year-end survey (2 NDCs) and $23.60 at the 2026 survey (4 NDCs): −19%, a thin comparison.

$0$36.202017: median $29.12 per mL, 2 NDCs priced2018: median $31.27 per mL, 2 NDCs priced2019: median $28.58 per mL, 2 NDCs priced2020: median $29.36 per mL, 2 NDCs priced2021: median $24.85 per mL, 6 NDCs priced2022: median $28.56 per mL, 6 NDCs priced2023: median $26.77 per mL, 4 NDCs priced2024: median $15.59 per mL, 4 NDCs priced2025: median $25.19 per mL, 4 NDCs priced2026: median $23.60 per mL, 4 NDCs priced201720192021202320252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2017 (2017-12-27)$29.12$25.25 to $32.982
2018 (2018-12-26)$31.27$26.34 to $36.202
2019 (2019-12-25)$28.58$24.68 to $32.472
2020 (2020-12-30)$29.36$25.06 to $33.652
2021 (2021-12-29)$24.85$21.03 to $28.686
2022 (2022-12-28)$28.56$26.03 to $31.096
2023 (2023-12-27)$26.77$24.37 to $29.164
2024 (2024-12-25)$15.59$14.85 to $16.324
2025 (2025-12-31)$25.19$22.62 to $27.774
2026 (2026-11-11)$23.60$20.57 to $26.634

Bimatoprost 0.01% Eye Drops

Generic

Priced once, at the 2026 year-end survey: $42.87 per mL across 6 NDCs.

Year-end surveyMedian per mLLowest to highestNDCs priced
2026 (2026-11-11)$42.87$39.49 to $43.466

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

How many companies make Bimatoprost?

The FDA Orange Book lists 9 generic makers as marketed in its largest dosage form for Bimatoprost, and the first generic approval is dated 1 December 2014. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Bimatoprost on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).